Yehuda Handelsman <br/><br/>
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works